Novel Mechanisms of Action in Multiple Sclerosis: Focus on BTK Inhibitors

home / peer-exchange / novel-mechanisms-of-action-in-multiple-sclerosis-focus-on-btk-inhibitors

Experts discuss Bruton's tyrosine kinase (BTK) inhibitors, which block the actions of B cells and may affect other cell types that can facilitate inflammation, recent key clinical data on BTK inhibitors in multiple sclerosis. and how to incorporate these novel agents into treatment plans once they become available.

© 2024 MJH Life Sciences

All rights reserved.